Brief: Obstructive Sleep Apnea Expected To Affect Nearly 77 Million US Adults By 2050, New Resmed Study Finds
27/08/2025 14:03
Aug 27 (Reuters) - Resmed Inc RMD.N: OBSTRUCTIVE SLEEP APNEA EXPECTED TO AFFECT NEARLY 77 MILLION U.S. ADULTS BY 2050, NEW RESMED STUDY FINDS Source text: ID:nGNX2sxpr8 Further company coverage: RMD.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on ResMed
See all newsCiti lifts ResMed's ASX-listed stock's target price after FX, valuation updates
S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT
S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT
Brief: Resmed - Enters Accelerated Share Repurchase Agreement To Repurchase $450 Million Of Common Stock - SEC Filing
S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT